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SUMMARY
The motility assay is the current gold standard for evaluating drug eﬀects on hookworm larvae and adults, however, among
other drawbacks the assay is time consuming, and prone to individual subjectivity. We evaluated six alternative in vitro
assays, namely the feeding inhibition assay, the colourimetric AlamarBlue®, MTT formazan and acid phosphatase activity
assays, as well as isothermal calorimetry and the xCELLigence System using Ancylostoma ceylanicum third-stage larvae,
stimulated third-stage larvae and adults. The performances of the assays were compared to the motility assay using three
standard drugs: albendazole, levamisole and ivermectin (100–1 μg/ml). None of the assays investigated oﬀered an advantage
over the motility assay, because they were all inapplicable to third-stage larvae, which were presumably metabolically and
physically too inactive. Among all assays tested the xCELLigence System performed best on adult worms as the test was
accurate, simple, required a minimal number of worms and oﬀered the possibility for conducting a medium-throughput
screening.
Key words: hookworm, Ancylostoma ceylanicum, in vitro assays, motility assay, feeding inhibition assay, acid phosphatase,
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INTRODUCTION
The hookworms,Ancylostoma duodenale andNecator
americanus infect an estimated 600 million people
worldwide and are major causes of global morbidity
accounting for as many as 22·1 million disability-
adjusted life years (DALYs) lost annually (Bethony
et al. 2006; Chan, 1997). Hookworm infections
belong to the so-called neglected tropical diseases
and occur mostly in the poorest regions of tropical
and subtropical countries (Bethony et al. 2006; Hotez
et al. 2008). School-age children, pregnant women
and the developing foetuses are particularly at risk of
suﬀering severe morbidities from hookworm infec-
tions (Brooker et al. 2004).
Currently, control of hookworms relies essentially
on regular anthelmintic treatment, mostly in the
framework of mass drug administration campaigns
(Harhay et al. 2010; Hotez, 2008; Hotez and Pecoul,
2010). Despite this, only ﬁve drugs (the two benzi-
midazoles albendazole and mebendazole, pyrantel
pamoate, levamisole and ivermectin) are recom-
mended by the World Health Organisation (WHO),
which have all been used since decades (WHO, 2011).
In terms of cure rates only albendazole is highly
eﬀective against hookworms (Keiser and Utzinger,
2010). In addition, resistance to these drugs is already
widely spread among livestock (Wolstenholme et al.
2004) and therefore there are concerns about the
emergence of drug resistance among human helminth
populations. Hence, there is a pressing need to dis-
cover and develop alternative anthelmintics (Geerts
andGryseels, 2001;Kaplan, 2004) and robust tools to
monitor helminths drug susceptibility.
Today, the few ongoing drug discovery eﬀorts
on human nematodes rely on low- to medium-
throughput in vitro whole organism drug screening.
In more detail, the current assay of choice, the
motility assay, is based on the microscopic evaluation
of the worms’ viability, following drug exposure and
subsequent stimulation of worms (Gill et al. 1991;
Kotze et al. 2004; Satou et al. 2001). The motility
assay can be performed with diﬀerent developmental
stages, and requires little laboratory equipment.
However, it is time consuming and prone to
subjectivity upon reading. The development of a
novel medium- to high-throughput in vitro assay
with a simple readout would therefore be a great step
forward in the ﬁeld of nematocidal drug discovery.
In this work, we aimed to evaluate several potential
alternative in vitro assays to evaluate drug eﬀects on
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A. ceylanicum. We assessed two viability markers,
Alamar Blue®, an indicator for metabolic cell func-
tion (Räz et al. 1997) and the MTT reduction assay,
which is based on a colourimetric reaction involving
pyridine nucleotides cofactors (Berridge and Tan,
1993; Mosmann, 1983). In addition, we measured
acid phosphatase, which is secreted in large amounts
by several nematode species in feeding stages, possi-
bly to promote extracorporeal digestion and tissue
penetration (Maki and Yanagisawa, 1980; Martinez-
Grueiro, 2002) and which is a good indicator of
the worms’ ﬁtness. We also evaluated the feeding
inhibition assay (Hawdon and Schad, 1990; Kopp
et al. 2008), and two fairly new technologies, namely
isothermal calorimetry (Braissant et al. 2010) and
the xCELLigence System (Roche Inc.) (Smout
et al. 2010). We analysed the eﬀect of albendazole,
levamisole and ivermectin on L3, stimulated L3 and
adults in these assays and compared ﬁndings with
results obtained with the current method of choice,
the motility assay. Finally, advantages and disadvan-
tages of the individual assays are highlighted.
MATERIALS AND METHODS
Drugs
Albendazole and ivermectin were purchased from
Sigma-Aldrich (Buchs, Switzerland), and levami-
sole-hydrochloride was obtained from Fluka (Buchs,
Switzerland). Stock solutions (5mg/ml) were pre-
pared for all drugs in 100% DMSO (Fluka, Buchs,
Switzerland) and stored at 4 °C.
Animals and parasite infections
Three-week-old male Syrian Golden hamsters were
purchased from Charles River (Sulzfeld, Germany).
The A. ceylanicum life cycle has been maintained
at the Swiss TPH since June 2009. Brieﬂy, hamsters
were immunosuppressed (0·5mg/l dexamethasone
(dexamethasone water-soluble, Sigma-Aldrich) in
the drinking water from one day before infection
onwards. They were orally infected with 150
A. ceylanicum L3, which had been assessed for
viability. Animals were kept in groups of 5 in
macrolon cages under environmentally-controlled
conditions (temperature: 25 °C, humidity: 70%,
light/dark cycle 12/12 hours) and had access to water
and rodent food (Rodent Blox, Eberle NAFAG,
Gossau, Switzerland). The current work was ap-
proved by the local veterinary agency based on
Swiss cantonal and national regulations (permission
no. 2070).
In vitro assays
General procedure
L3: In 96-well plates, 30 L3 per well were incubated
in 200 μl HBSS supplemented with 25 μg/ml
amphotericin B (Sigma-Aldrich), 10000U/ml peni-
cillin and 10mg/ml streptomycin (Sigma-Aldrich)
and drug dilutions ranging from 100 to 1 μg/ml,
ﬁnal concentration. The plates were incubated for
72 hours at room-temperature, in dark and humid
conditions.
Stimulated L3: Third-stage larvae are in “dauer”
stage and do not feed or show any metabolic activity.
In the feeding inhibition assay, L3 are brought into
the fourth stage, where they resume feeding, and are
then exposed to drugs. We used a modiﬁed protocol
from Kopp and colleagues for this transformation
(Kopp et al. 2008).
L3 were pelleted (3000×g, 3 minutes) and cleaned
in 1% HCl 1M in tap water for 10 minutes at 37 °C
and then washed twice in RPMI medium (RPMI
1640 (Gibco) supplemented with 0·5% ALBUMAX
II (Gibco), 25 mMHEPES (Sigma-Aldrich), 25 mM
NaHCO3 (Sigma-Aldrich), 25 μg/ml amphotericin
B (Sigma-Aldrich), 10000U/ml penicillin and
10mg/ml streptomycin (Sigma-Aldrich), 15% v/v
foetal calf serum (FCS, Gibco), and 20mM reduced
L-glutathione (Fluka)). Thirty L3 per well were
incubated in 200 μl RPMI medium for 24 hours at
37 °C. In a next step 100 μl medium were removed
and replaced with 100 μl of the respective drug
dilution in RPMI medium. The plates were incu-
bated for another 72 hours at 37 °C, 5% CO2.
Adult stage: In 48-well plates, 3–4 adult worms of
both sexes were incubated per well in 1ml HBSS
medium supplemented with 25 μg/ml amphotericin
B (Sigma-Aldrich), 10000U/ml penicillin and
10mg/ml streptomycin (Sigma-Aldrich), 10% v/v
FCS (Gibco), and drug dilutions (100 to 1 μg/ml).
The plates were incubated for 72 hours at 37 °C,
5% CO2.
Larval and adult motility assay
Following incubation of L3 and adults with drugs as
described above, larval and adult motilities were
evaluated under an inverted microscope (magniﬁ-
cation 20×, Carl Zeiss, Germany), following addition
of hot water (*80 °C, [100 μl] L3, [500 μl] adult
worms) and exposure to the microscope light. Larvae
showing no movement after stimulation were
classiﬁed as dead and the percentage survival was
established for each well. The viability of adult
worms was assessed using a motility scale from 2
(normal movements, worms healthy) to 0 (no move-
ments, death) and converted into percentage viabil-
ity. Motility assays were conducted at least twice in
triplicate.
Feeding inhibition assay
Following incubation of stimulated L3 (as described
above), 100 μl medium were removed from each well
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and replaced with bovine albumin conjugated with
ﬂuorescein isothiocyanate (1·25 mg/ml, ﬁnal concen-
tration, Sigma-Aldrich) and the plate was incubated
for 3 hours at 37 °C. Larvae were washed 3 times
in PBS, ﬁlled in individual 1·5 ml Eppendorf tubes
and distributed again into wells. Using an inverted
ﬂuorescence microscope (Carl Zeiss, Germany, mag-
niﬁcation 100–200×, excitation: 450–490 nm, emis-
sion: 520 nm), larvae whose intestinal tract was
stained by more than 50% in the length were
considered ﬁt and counted (Kopp et al. 2008). The
percentage survival was calculated for each well.
The motility of worms was assessed in parallel
without adding hot water. The assay was conducted
three times.
Alamar Blue® assay
TheAlamar Blue assaywas adapted from the protocol
developed by Räz et al. (Räz et al. 1997). After
72 hours of incubation with drugs (as summarized
above), the worms (adults, L3 and stimulated L3)
were transferred into 200 μl freshly supplemented
HBSS medium (2 adult worms, or 30 L3 per well) in
a 96-well plate. Ten μl resazurin (Sigma-Aldrich,
125mg/l) were added to each well. The plates were
then incubated at 37 °C, 5% CO2 for 5 hours (up to
24 hours for adults). The resulting absorbance
was measured every hour for 5 hours (and once
after 24 hours for adults) in each well (excitation:
536 nm, emission: 588 nm, Spectramax®Gemini XS,
Molecular devices, USA). The assay was carried out
at least twice.
MTT reduction assay
The MTT assay was run according to James and
colleagues with slight modiﬁcations (James and
Davey, 2007). Drug activity was tested using a single
adult worm, or 30 L3 per well (in duplicate) in
96-well plates (total volume 200 μl). After 72 hours of
incubation, the worms’ viability was assessed micro-
scopically (inverted microscope, magniﬁcation 20×)
without adding hot water. One hundred μl were
removed from each well and replaced with 100 μl
MTT (thiazolyl blue tetrazolium bromide, Sigma-
Aldrich) solution (2·5 mg/ml ﬁnal concentration).
The plates were incubated for up to 3 hours at 37 °C,
5%CO2.Thewormswerewashed once in sterile PBS,
transferred to 50 μl DMSO 100% (Fluka, Buchs,
Switzerland) and allowed to de-stain for 20 minutes
at 37 °C. The resulting absorbance was measured
at 588 nm, Versamax® (Molecular Devices, USA).
The assay was performed at least two times.
Acid phosphatase activity assay
The assays were carried out as described by
Martinez-Grueiro et al. (Martinez-Grueiro, 2002)
with small changes in the protocol. After 72 hours of
incubation, adult worms were transferred into 1ml
supplemented HBSS medium and incubated for
another 5 hours at 37 °C, 5% CO2. The motility
was assessed before adding reagents, without adding
hot water. The supernatant was frozen at −20 °C or
directly used for the following steps. Two times
100 μl of the supernatant were removed and incu-
bated for either 1 or 2 hours at 37 °C, 5% CO2 with
50 μl fresh ρ-nitrophenyl phosphate (pNPP, Sigma-
Aldrich) solution (10 mM, in sodium acetate buﬀer
pH 4). The reaction was blocked with 70 μl NaOH
0·3 M and the absorbance measured at 405 nm
(Versamax®, Molecular Devices, USA). For L3 and
stimulated L3, 100 μl supernatant were removed
from the drug assay plate directly and incubated for
2 hours with pNPP as described above. The assay was
conducted three times.
Isothermal micro- and nanocalorimetry
Isothermal calorimetry measures quantitatively exo-
and endothermic heat ﬂow of metabolic processes,
and has already shown applicability using diﬀerent
helminth models (Braissant et al. 2010; Kirchhofer
et al. 2011; Manneck et al. 2011). The endpoint used
in this study was the time of death of the worms.
A thermostated (37 °C) 48-chanel microcalorimeter
(TAM 48, TA Instruments, New Castle, Delaware,
USA) or a 3-channel nanocalorimeter (TAM-III, TA
Instruments, NewCastle, Delaware,USA) were used
to measure the heat ﬂow ofA. ceylanicum over at least
3 days. Brieﬂy, 100, 200 or 500L3 (microcalorimetry)
or 8 adult worms (micro- and nanocalorimetry) were
distributed into sterile glass ampoules containing
2·7 ml of supplemented HBSS medium. The system
was allowed to equilibrate for at least 12 hours before
injection of 0·3 ml pre-warmed drug solutions (or
DMSO solutions as control conditions) and allowed
to equilibrate again for around 12 hours. The heat
ﬂow was continuously recorded in each ampoule and
summarized to obtain an eﬀective sampling rate of
one data point every 10 minutes. Noise amplitudes
observed in heat ﬂow curves reﬂect the worms’motor
activity. The noise amplitude curve, following
exponential decay, is based on absolute values of the
amplitudes of noise obtained for 20 minutes over the
entire course of the experiment. The intersection of
the sample curve with the background line deﬁnes
the death of worms (Kirchhofer et al. 2011; Manneck
et al. 2011). The nanocalorimeter oﬀers a greater
sensitivity, in the range of 20 nW. The microcalori-
metry assay was performed three times, the nano-
calorimetry assay was performed once.
xCELLigence System
The xCELLigence System (Roche Inc.) oﬀers an
automated real-time measurement of the cellular
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electrical impedance (Xing et al. 2005) across inter-
digitated micro-electrodes integrated on the bottom
of the 96-well plates (E-plates). An innovative ap-
plication of the system for nematode worms was
recently described, monitoring motilities of Haem-
onchus contortus, Strongyloides ratti, Ancylostoma
caninum and Schistosoma mansoni (Smout et al.
2010). Measurements were displayed in the RTCA
controller software (Roche Inc.) The xCELLigence
System was equilibrated either to room-temperature
or to 37 °C for 2 hours before the experiment was
started. Then 100 L3 or stimulated L3 or one adult
worm (in a volume of 100 μl) were added to the wells.
Measurements started 10 minutes before the pre-
warmed drugs were added (100 μl). The impedance
was recorded in each well every minute for 72 hours
post-incubation with drugs. The signal amplitudes
(noise amplitudes) were analysed from each well. As
described above, the intersection of the sample
motility curve (exponential decay) with the back-
ground curve is the endpoint of the analysis and
represents death of worms. The assay was performed
three times.
Statistical analysis
All data were analysed and plotted in Excel
(Microsoft Oﬃce 2003). The motility data were
analysed with the Fisher’s exact test (L3 survival),
and Mann-Whitney U test (adults’ viability), using
StatsDirect (version 2.4.5; StatsDirect Ltd;
Cheshire, UK). The correlations between the feeding
inhibition assay and the acid phosphatase assay with
the corresponding motility assay data were tested
using the Spearman rank correlation coeﬃcient, in
StatsDirect. Microcalorimetry and xCELLigence
raw data were plotted using R (R 2.12.0, R Devel-
opment Core Team). The exponential decay curve
was deﬁned by the equation H0e
−μt+c, where
μ represents the decay rate of noise amplitudes
(motor activity), H0 is the initial starting point, t is
time and c is the short term noise of the calorimeter.
The repartition of death time points over the course
of the experiment was assessed using the Fisher’s
exact test (StatsDirect).
RESULTS
Larval and adult motility assay
The activities of albendazole, levamisole and iver-
mectin on L3 and adult worms using the motility
assay are summarised in Fig. 1. Brieﬂy, ivermectin
showed the best activity against both hookworm
stages 72 hours after incubation start, with 100 μg/ml
of the drug killing 86·1 and 100% of larvae and adults
(both P-values 40·001), respectively. Surviving
larvae showed spastic movements, sometimes just at
one end. Levamisole exhibited a high activity with
only 2·4% of L3 surviving following incubation with
100 μg/ml of the drug for 72 hours (P<0·001). On the
other hand adults were nearly unaﬀected by levami-
sole (viability >84%, all P values >0·05). Albendazole
displayed a moderate eﬀect against L3 (survival of
64·0–77·4% at 1–100 μg/ml, all P-values <0·001), but
showed no eﬀect against adults (all P values >0·05).
Feeding inhibition assay
Levamisole and ivermectin were tested against
stimulated L3 in the feeding inhibition assay
(Fig. 2). On average, 84·9% of the larvae in the
control wells displayed a ﬂuorescent intestinal tract,
which fulﬁls the criteria set by Moser et al. for a
successful activation (Moser et al. 2005). Levamisole-
treated parasites exhibited between 49·0 and 66·0%
gut staining, whereas survival was 0% at all con-
centrations using the motility assay (not shown).
A
B
Fig 1. Anthelmintic activity of albendazole, levamisole
and ivermectin against Ancylostoma ceylanicum L3 (A)
and adult worms (B). The percentage survival or the
viability scores are expressed as percentage of the
controls. DMSO CTRL=DMSO control,
ABZ=albendazole, LEV=levamisole, IVM=ivermectin.
Black bars show 100 μg/ml; white bars show 10 μg/ml;
striped bars show 1 μg/ml. The assays were conducted at
least twice in triplicates. * p40·05 (A: Fisher’s exact test;
B: Mann-Whitney U test).
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Fluorescent guts were observed in 49·3 to 56·8%
of larvae following incubation with ivermectin,
while 47·3 to 74·4% still showed movement in the
corresponding motility assay (not shown). With both
treatments, no concentration-dependency and a
poor reproducibility were observed. No correlation
between the feeding inhibition assay and the corre-
sponding motility data was found (Spearman rank
correlation coeﬃcient, ρ=0·15, P=0·233 for positive
correlation).
Alamar Blue® assay
None of the tested stages (L3, stimulated L3 and
adult worms) was able to convert resazurin into
resoruﬁn within 5 hours. The medium turned slowly
violet only after 5 hours. Twenty-four hours post-
incubation, the ﬂuorescence intensity measured was
not homogeneously distributed between wells, with
emissions ranging from 3059–7427, compared to
2497 on average for the medium only.
MTT reduction assay
Following incubation of L3 and stimulated L3
with MTT, no reduction of the marker occurred
and therefore neither the larvae nor the medium
changed colour. Adult worms’ internal tissues turned
violet but their teguments remained colourless. In
general, no reproducible staining pattern was ob-
served within one treatment group (and among
controls), and staining did not correspond to their
capacity to move as observed with the motility assay.
No reproducible absorbances could be measured at
588 nm.
Acid phosphatase activity assay
Neither L3 nor stimulated L3 triggered a colouri-
metric reaction following addition of pNPP (10mM
solution). Adult worms produced measurable
amounts of the enzymes. The absorbance measured
for control adult worms reached 1·6. However, the
signal to noise ratio was low. The background noise
produced by medium alone was high (0·5), similar
to the absorbance of treated worms (0·48–0·81).
In addition, no concentration-dependency was ob-
served (Fig. 3). Finally, no correlation (Spearman
rank correlation coeﬃcient, ρ=0·24, P=0·11 for
positive correlation) was determined between the
results of the acid phosphatase secretion assay and
the motility of the worms (assessed before the acid
phosphatase activity assay was started).
Isothermal micro- and nanocalorimetry
Microcalorimetry: Neither L3 nor stimulated L3
(up to 500 per ampoule) exhibited suﬃcient heat
production for a stable signal. Preliminary exper-
iments revealed that 8 worms was the minimum
number of worms to measure a suﬃciently large
signal, in the range of 2–3 μW. Eight adult worms per
ampoule were treated with 100 μg/ml levamisole,
100 μg/ml ivermectin, or the corresponding amount
of DMSO. Mortality rates of adult worms were
determined by comparing noise amplitudes in their
heat ﬂows, which derive from worm motor activities
of drug-treated and control worms. The thermogenic
noise of 8 dead worms was used as background noise
(dotted line) and deﬁned as 0·13 μW (not shown).
Fig. 4 shows the heat ﬂow pattern produced by
control worms over 72 hours. The time-points of the
death of worms are summarized in Table 1. Two
control worms died between 24 and 72 hours post
injection of DMSO, while 2 control worms were still
alive at the end of the experiment. The noise signals
were reduced to a level not diﬀerent than that of dead
control worms within 12 hours following addition of
Fig. 3. Acid phosphatase activity assay for sensitivity of
Ancylostoma ceylanicum adult worms to albendazole,
levamisole and ivermectin. Med=medium only, DMSO
CTRL=DMSO control, ABZ=albendazole,
LEV=levamisole, IVM=ivermectin. Black bars show
100 μg/ml; white bars show 10 μg/ml; striped bars show
1 μg/ml. Data points derive from three independent
experiments.
Fig. 2. Feeding inhibition assay. Percentage of stimulated
L3 exhibiting ﬂuorescent intestinal tract following
treatment with levamisole or ivermectin. DMSO
CTRL=DMSO control, LEV=levamisole,
IVM=ivermectin. Black bars show 100 μg/ml; white bars
show 10 μg/ml; striped bars show 1 μg/ml. Data points
derive from three independent experiments.
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levamisole and ivermectin, signiﬁcantly diﬀerently
from the controls (both P=0·03).
Nanocalorimetry: The absolute heat ﬂow obtained
from control worms after equilibration of the system
(about 12 hours) remained in the range of 1·5–2·5 μW
during the whole experiment (Fig. 5). Heat ﬂows
recorded from levamisole- and ivermectin-treated
worms were not higher than about 1·5 μW, reﬂecting
the drug eﬀects. Signals from control and drug-
treated worms remained stable over the whole
experiment duration. Great noise amplitudes were
observed in the control ampoule, whereas they were
ﬂattened in the treated ones, reﬂecting the loss of
motor activities. The dead worms data were recorded
in a separate experiment and no drug or medium was
injected. The absolute heat ﬂow from this ampoule
was higher, in the range of 2·5 μW, but stable over
time and displaying minimal noise amplitudes.
xCELLigence System
Electrical impedance was measured from adults but
was not detected in the 100 L3 nor in the stimulated
L3. One adult worm per well was treated with
100 μg/ml albendazole, 100 μg/ml levamisole,
100 μg/ml ivermectin, or the corresponding amount
of DMSO. The noise produced by one dead worm
was used as background noise (dotted line) and was
0·0044 (cell index, not shown). Out of 7 control
worms analysed, 1 worm died between 24–48 hours
and 2 worms died between 48–72 hours post-
incubation with drugs. Four worms remained alive
over the entire examination period of 72 hours
(Table 2). Fig. 6 shows the impedance signal curve
produced by a representative control worm, still alive
72 hours after addition of DMSO. Ivermectin
reduced the impedance signal to a level not diﬀerent
than that of dead control worms within 12 hours
following addition of the drug (P40·01). No clear
activity pattern was observed for albendazole and
levamisole. Worms died at diﬀerent time points
following incubation with both drugs (Table 2)
(both P-values >0·05).
DISCUSSION
An ideal in vitro assay for drug sensitivity testing
should be precise, sensitive, simple, fast and cost
eﬀective. Many in vitro assays used to study drug
Fig. 4. Heat ﬂow pattern of untreated adult Ancylostoma ceylanicum worms (n=8). The produced noise obtained for
20 minutes is averaged over 72 hours. Noise amplitude values follow exponential decay (solid line). The following
equation was applied: H0e
−μt+c, where μ represents the decay rate of noise amplitudes (motor activity), H0 is the initial
starting point, t is time and c the short term noise of the microcalorimeter. The system background noise is shown as
dotted line, deﬁned as 0·13 μW. The intersection of the sample curve (solid line) with the background line (dotted line)
is the endpoint of worm motility and corresponds to the death of worms.
Table 1. Time-points of worms’ death measured
by isothermal microcalorimetry, over 72 h after
treatment with 100 μg/ml levamisole, ivermectin or
DMSO (8 worms per ampoule)
(Death in the ampoule is deﬁned as the intersection
between the noise amplitude in the heat ﬂow curve and
the background noise line. Death was determined in 3
(ivermectin) or 4 ampoules for each treatment. The
repartition of death time points is shown by the proportion
and analysed using the Fisher’s exact test (*P40·05),
cumulating the time ranges.)
Time-
point of
death
Control
(death/total
ampoules)
Levamisole
(death/total
ampoules)
Ivermectin
(death/total
ampoules)
0–12 h 0 4/4* 3/3*
12–24 h 0 — —
24–48 h 1/4 — —
48–72 h 1/4 — —
>72 h 2/4 — —
Fig. 5. Absolute heat ﬂow of Ancylostoma ceylanicum
adult worms recorded with an isothermal nanocalorimeter
over 72 hours. 100 μg/ml levamisole, ivermectin or
DMSO were injected at time=0, indicated by the arrow.
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eﬀects on nematodes have drawbacks (Taylor et al.
2002). For instance, the egg-hatch test (Le Jambre,
1976) is only suitable for the benzimidazoles, since
most drugs have no eﬀect on A. ceylanicum egg
hatching (Tritten et al., manuscript submitted). The
motility meter was found to lack suﬃcient sensitivity
to detect drug susceptibility of bovine intestinal
nematode larval stages (Demeler et al. 2010).
Although cheap and simple, the motility assay is
time consuming and prone to individual subjectivity.
An improved drug sensitivity in vitro assay might
therefore aid the development of novel hookworm
drug therapies. In the present work, we studied the
applicability of six alternative in vitro assays using
both A. ceylanicum larval and adult stages, based
on well-established methods and more recent tech-
nologies.
Our ﬁndings, summarized in Table 3, show that
the xCELLigence System was the only method
comparing favourably to the motility assay, whereas
isothermal microcalorimetry, the colourimetric as-
says as well as the ﬂuorescence-based test presented
no advantage over the motility assay.
None of the tested assays was suitable for
stimulated or normal L3, the preferred stage for
in vitro testing, since they survive for several weeks
after collection, and the use of adult worms requires
killing of the hamster host. Third-stage larvae are
in the developmentally arrested non-feeding stage,
where physiological processes are greatly reduced
(Burnell et al. 2005; O’Riordan, 1989; O’Riordan,
1990), which might explain this result. Furthermore,
their mouth and anus are sealed oﬀ (Cassada and
Russell, 1975), limiting contacts with the environ-
ment. Several genes are diﬀerentially expressed upon
feeding resumption by stimulated L3 (Moser et al.
2005), allowing a parasitic metabolic life, and adults
are considered fully metabolically active (O’Riordan,
1989, 1990). However, it has been shown that the
onset of development upon feeding resumption leads
to more gene repressions than up-regulations (Moser
et al. 2005).
The xCELLigence System oﬀered the advantage
of the format (96-well plate) and suﬃciently strong
signals could be obtained with only one adult worm
per well. On the other hand, one hundred larvae
did not yield a signal that could be detected and
measured. Smout et al. showed that a large number
of Haemonchus contortus or Strongyloides ratti larvae
were necessary to exhibit measurable cell indices
Table 2. Time-points of worms’ death measured by the xCELLigence
System, over 72 h after treatment with 100 μg/ml levamisole, ivermectin
or DMSO (1 worm per well)
(Death in the well is deﬁned as the intersection between the noise in the impedance
curve and the background noise line. Death was determined in 3–7 wells for each
treatment. The repartition of death time points is shown by the proportion and
analysed using the Fisher’s exact test (*P40·05), cumulating the time ranges.)
Time-point
of death
Control
(death/total
wells)
Albendazole
(death/total
wells)
Levamisole
(death/total
wells)
Ivermectin
(death/total
wells)
0–12 h 0 1/7 2/3 7/7*
12–24 h 0 1/7 0 —
24–48 h 1/7 0 0 —
48–72 hours 2/7 2/7 1/3 —
> 72 h 4/7 3/7 — —
Fig. 6. Impedance pattern of adult Ancylostoma ceylanicum worms (n=1) measured with the xCELLigence System.
The produced noise obtained for 20 minutes is averaged over 72 hours. Noise amplitude values follow exponential decay
(solid line). The following equation was applied: H0e
−μt+c, where μ represents the decay rate of noise amplitudes
(motor activity), H0 is the initial starting point, t is time and c – the short term noise of the xCELLigence System. The
system background noise is shown as dotted line, deﬁned as 0·0044 (cell index). The intersection of the sample curve
(solid line) with the background line (dotted line) is the endpoint of hookworm motility and corresponds to the death of
worms.
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(Smout et al. 2010), which is a great disadvantage for
medium- to high-throughput assays. The cost of the
xCELLigence apparatus and the E-plates might also
be a drawback. In addition, untreated control worms
died faster than in other in vitro assays, presumably
due to incubation in a small amount of medium
(200 μl) for 72 hours. Hence, with the xCELLigence
it is not possible to run drug assays for long periods.
It is interesting to note that according to
xCELLigence, death occurred later in one third of
the levamisole-treated worms, compared to data from
microcalorimetry. It would be necessary to investi-
gate a larger sample size to ﬁnd out whether a
variation in responsiveness to levamisole exists.
However, it is possible that hookworms analysed
were not equally ﬁt at the start of the assay. In both
assays, the results obtained following treatment with
levamisole do not correspond to the motility data.
Although isothermal microcalorimetry is generally
accepted as sensitive and accurate, several limitations
were noted analysing drug eﬀects on A. ceylanicum.
First, it was necessary to place several adult hook-
worms per ampoule to obtain a suﬃciently strong
signal, a signiﬁcant disadvantage in terms of costs and
ethical requirements for research involving animal
hosts. Similarly to the other assays analysed, it was
not possible to run the assay with larval stages.
Second, the injection of the drugs triggered a
perturbation of the system with great noise ampli-
tudes being recorded for at least 8 hours and it was
therefore necessary to re-equilibrate the system for
several hours before drug eﬀects on the noise
amplitudes produced by the worms could be
measured. For fast acting drugs it is therefore not
possible to determine the exact time point of death.
Our ﬁndings are in contrast to studies using
isothermal microcalorimetry with the helminths
Schistosoma mansoni, Fasciola hepatica or Trichuris
muris, where few worms generated suﬃciently stable
heat ﬂows and quickly re-equilibrated following drug
injections (Kirchhofer et al. 2011; Manneck et al.
2011; Silbereisen et al. 2011). Since the samemachine
was used in all of these experiments, the observed
insensitivity of hookworms compared to whipworms
cannot be explained by equipment diﬀerences.
Increased sensitivity and signal stability was
obtained using nanocalorimetry. However, the ob-
served heat ﬂows in control versus treated worms
were very similar and the baseline signal seems to
shift from an experiment to the next, as it was
observed with the higher absolute heat ﬂow of dead
worms, recorded separately. It is not unlikely that
microcalorimetry might record some non-biological
processes contributing to the higher baseline of dead
worms. Possible processes might include chemical/
enzymatic reaction initiated by the killing of the
worms (performed using ethanol or freezing) or
microcalorimeter baseline shift. As observed with
microcalorimetry, the motor activity reﬂected by the
noise amplitudes measured in the nanocalorimeter
constituted the largest diﬀerence between control and
treated conditions.
Our results obtained with the motility assay are in
agreement with previous ﬁndings (Misra et al. 1981;
Richards et al. 1995; Kotze et al. 2004). Brieﬂy,
albendazole had a weak eﬀect against L3 and a
moderate eﬀect against adult worms. The low activity
observed against larvae at 100 μg/ml albendazole
might be explained by precipitation of the drug in
the medium. Levamisole showed excellent eﬃcacy at
100–10 μg/ml against larvae, but lacked activity
against adults. Ivermectin strongly aﬀected larvae
and adult worms.
The feeding inhibition assay was ﬁrst described by
Hawdon and Schad (Hawdon and Schad, 1990,
1992), and proved useful in studies with A. caninum
(Kopp et al. 2008). However, Kopp and colleagues
identiﬁed lack of suﬃcient sensitivity with this assay,
while testing resistance to pyrantel (Kopp et al.
2008).We found this assay to be time-consuming and
tricky because of the numerous preparation steps,
where larvae can be lost or damaged. In addition, the
staining intensity of worms was weak, although the
exsheathment did occur. The feeding inhibition assay
therefore does not oﬀer an advantage over the
motility assay.
Table 3. Summary of the tested assays and of their performance in testing drug susceptibility against
A. ceylanicum larval and adult stages
(Tests evaluated unfavourably are scored with “−”, those evaluated favourably, with a “+”.)
Assays
Motility
Acid
phosphatase MTT
Feeding
inhibition
Alamar
Blue
Micro-
calorimetry
xCELLigence
System
T
es
te
d
st
ag
e L3 Gold
standard
− − − − − −
Stimulated L3 Not
tested
− − − − − −
Adult worms Gold
Standard
− − − − − +
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Also none of the tested colourimetric assays was
found to perform satisfactorily. In general, colouri-
metric assays are diﬃcult to carry out with organisms
as large asA. ceylanicum adult worms, whose size can
vary, because the endpoints depend directly on the
number of living cells (Mosmann, 1983; Räz et al.
1997). The Alamar Blue assay, which determines
the metabolic mitochondrial biotransformation of
resazurin into resoruﬁn, was not suitable for larval
stages. Furthermore, the conversion of resazurin into
resoruﬁn by adult worms was very slow (no ﬂuor-
escent emission compared to medium within
5 hours), hence the applicability of the Alamar Blue
assay was considered limited, in particular since
this assay is highly sensitive to contaminations.
We expected adult worms to reduce the dye much
more quickly, as it is the case for Trichuris muris
(Silbereisen et al. 2011) and therefore cannot explain
this ﬁnding. It might be possible that either resazurin
is not taken up suﬃciently, or the mitochondrial
metabolic activity is lower in A. ceylanicum than in
other nematode species.
Upon incubation with MTT, larval stages did not
detectably reduce MTT to formazan and revealed
no staining. Formazan formation relies on pyridine
nucleotides cofactors (Berridge and Tan, 1993), and
as suggested before, larval and adult hookworm
metabolisms might greatly diﬀer. It was reported
elsewhere that L3 of Caenorhabditis elegans were able
to take up MTT, whereas those of H. contortus were
not (James and Davey, 2007). In the same report, the
authors suggested that the protective sheath of the
L3 might prevent dye uptake, presumably occurring
by diﬀusion. In our experiments, adults got stained,
however only in an inhomogeneous and non-
reproducible manner, not supporting the hypothesis
of dye diﬀusion. It is worth mentioning that
ivermectin-treated worms, paralysed if not dead,
were less intensively stained than control or levami-
sole-treated worms. Overall, our results support the
suggestion that MTT uptake occurs via pharyngeal
pumping (Smith et al. 2009).
Finally, neither L3 nor stimulated L3 were able to
trigger any colourimetric reaction in the acid phos-
phatase assay.Results fromthe adult acid phosphatase
activity assay showed no correlation with the adult
motility assay. For example, while according to the
motility assay, ivermectin-treated worms were dead,
the acid phosphatase production by ivermectin-
treated worms was still high at the highest concen-
tration tested. It is possible, that ivermectin-treated
worms might not be dead, but paralysed instead
(Martin, 1997), with some metabolic activity still
taking place. In addition, no concentration depen-
dency eﬀect was observed for ivermectin using the
acid phosphatase activity assay. In contrast to our
study,Martinez-Grueiro showed a clear inhibition of
Heligmosomoides bakeri adult worms’ acid phospha-
tase production following treatment with ivermectin.
In conclusion, in the present work seven test
systems were examined for their usefulness in
investigations of drug eﬀects on hookworms. With
exception of the motility assay, the gold standard,
none of the presented assays was applicable to L3.
Using adult worms, the xCELLigence System
compared favourably to the motility assay. It was
found convenient especially for fast-acting drugs,
required aminimal amount of worms and would oﬀer
the possibility to conduct a medium-throughput
screening. The results are highly accurate, since a
precise endpoint can be obtained. However, ad-
ditional drugs should be tested to conﬁrm the
potential advantage of the xCELLigence System
over the motility assay in hookworm assays.
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